Philip Morris International Recognized Among World’s Top Sustainable Businesses with “Triple A” Score from CDP
Philip Morris International Inc. (PMI) (NYSE: PM) today announced its sustainability efforts have been recognized by two leading environmental organizations: CDP, the international nonprofit whose global disclosure system is used by investors, companies, and municipalities to measure and manage their environmental impacts, and the Science Based Targets initiative (SBTi), which drives ambitious climate action in the private sector by enabling companies to set meaningful emissions reduction targets.
André Calantzopoulos, PMI’s CEO, said, “Strong action must be taken to reduce the risks of climate change impacts and stop the destruction of nature. At PMI, we are investing in innovative programs and taking a multidisciplinary approach to reduce the environmental impact of our products, operations, and value chain.” He continued, “We firmly believe that by integrating sustainability into every aspect of our company, we will have a positive impact on both the long-term resilience of our business and the well-being of society. The validation of our efforts by CDP and SBTi reinforces that we’re on the right path and demonstrates the commitment of our teams and suppliers, who play an essential role in making our sustainability ambitions a reality.”
CDP has recognized PMI as a global environmental leader. Of the more than 5,800 organizations scored, PMI is one of only 10 companies worldwide to receive the “Triple A” score, which acknowledges the company’s best-in-class efforts in tackling climate change, as well as acting to protect forests and water security. This marks the seventh year that PMI has ranked on CDP’s A List for Climate Change. For the previous year, PMI also earned a position on the Water Security A List, and an A- for its forest disclosure. Combined, CDP’s most recent rankings place PMI among the select few to achieve a Triple A score and among the world's most pioneering companies leading on environmental transparency and performance.
Further, SBTi verified PMI’s emissions reduction targets, confirming that PMI’s environmental efforts are grounded in science and consistent with the reductions required to meet the goals of the Paris Climate Agreement and limit global warming to 1.5 °C. SBTi’s validation emphasizes that PMI’s carbon reduction strategy is aligned with climate science to prevent the most damaging effects of climate change.
Jennifer Motles, Chief Sustainability Officer at PMI, said: “Despite the unprecedented challenges brought on by the global pandemic, we have not deviated from our efforts to be a more sustainable company. I am incredibly proud of our teams and suppliers around the world, whose dedication to combating the risks of climate change has made us one of a handful of companies recognized as a leader on corporate environmental transparency by both CDP and SBTi. These monumental achievements demonstrate not only the seriousness we attribute to ESG-related matters but also the level of expertise, talent, and passion our company is putting toward achieving our long-term targets and ultimately making impactful change happen.”
Earlier this year, PMI released its first-ever Integrated Report highlighting the progress made in 2019 toward a smoke-free future and the company’s performance in environmental, social, and governance (ESG) related areas. The report discloses the broad range of activities PMI is undertaking to achieve carbon neutrality in its direct operations (scopes 1 + 2) by 2030 and across its entire value chain (scopes 1 + 2 + 3) by 2050. In November, the company integrated its sustainability function under the leadership of PMI’s Chief Financial Officer, further reinforcing that PMI’s sustainability strategy is embedded in every aspect of its business.
Water stewardship and sustainable forest management are also a significant part of PMI’s efforts to reduce its environmental footprint. As the company increases its production capacity for smoke-free products, it is evolving its water strategy, with clean technology investments delivering water recycling. These efforts are guided by the Alliance for Water Stewardship standard, through which the company has had six factories certified. To combat deforestation and protect biodiversity, PMI has developed a zero deforestation manifesto and has set a goal to have a net positive impact on forests associated with its tobacco supply chain by 2025. Additionally, as part of PMI’s Good Agricultural Practices program, all tobacco suppliers and contracted farmers are expected to use and manage natural resources sustainably and minimize negative impacts on the environment.
Paul Simpson, CEO of CDP, said: “We extend our congratulations to all the companies on this year’s A List. Taking the lead on environmental transparency and action is one of the most important steps businesses can make and is even more impressive in this challenging year marked by COVID-19. The scale of the risk to businesses from climate change, deforestation, and water insecurity is enormous, and we know the opportunities of action far outweigh the risks of inaction. Leadership from the private sector will create an ‘ambition loop’ for greater government action and ensure that global ambitions for a net zero sustainable economy become a reality. Our A List celebrates those companies that are preparing themselves to excel in the economy of the future by taking action today.”
Since announcing its commitment to a smoke-free future in 2016, PMI has actively focused its resources on developing, scientifically substantiating, and responsibly commercializing smoke-free products that are less harmful than smoking, with the aim of replacing cigarettes with smoke-free alternatives as soon as possible for those adults who would otherwise continue to smoke. The biggest positive impact PMI can have on society is to transform its business, and thus the company places this atop its sustainability priorities. As PMI rapidly progresses toward achieving its vision of a smoke-free future, it continues to enhance its sustainability efforts and embed sustainability into every aspect of its business.
The full list of companies on this year’s CDP A List is available here, along with other publicly available company scores: www.cdp.net/en/companies/companies-scores.
Additional information on PMI’s sustainability activities is available at PMI.com/Sustainability.
Note to editors
Philip Morris International: Delivering a Smoke-Free Future
Philip Morris International (PMI) is leading a transformation in the tobacco industry to create a smoke-free future and ultimately replace cigarettes with smoke-free products to the benefit of adults who would otherwise continue to smoke, society, the company, and its shareholders. PMI is a leading international tobacco company engaged in the manufacture and sale of cigarettes, as well as smoke-free products and associated electronic devices and accessories, and other nicotine-containing products in markets outside the United States. PMI ships a version of its smoke-free devices and consumables authorized by the U.S. Food and Drug Administration to Altria Group, Inc. for sale in the United States under license. PMI is building a future on a new category of smoke-free products that, while not risk-free, are a much better choice than continuing to smoke. Through multidisciplinary capabilities in product development, state-of-the-art facilities, and scientific substantiation, PMI aims to ensure that its smoke-free products meet adult consumer preferences and rigorous regulatory requirements. For more information, please visit www.pmi.com and www.pmiscience.com.
CDP is a global nonprofit that drives companies and governments to reduce their greenhouse gas emissions, safeguard water resources and protect forests. Voted number one climate research provider by investors and working with institutional investors with assets of US$106 trillion, we leverage investor and buyer power to motivate companies to disclose and manage their environmental impacts. Over 9,600 companies with over 50% of global market capitalization disclosed environmental data through CDP in 2020. This is in addition to the hundreds of cities, states and regions who disclosed, making CDP’s platform one of the richest sources of information globally on how companies and governments are driving environmental change. CDP is a founding member of the We Mean Business Coalition. Visit https://www.cdp.net/en or follow us @CDP to find out more.
The full methodology and criteria for the A List is available on CDP’s website at: https://www.cdp.net/en/companies/companies-scores.
Philip Morris International
T. +1 433 0447
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Alaska Cargo and Cold Storage Launches Major Addition to the Global Cold Chain25.1.2021 08:01:00 EET | Press release
Alaska Cargo and Cold Storage, LLC (ACCS) and the State of Alaska executed a 55-year lease agreement at Ted Stevens Anchorage International Airport (ANC), marking a major milestone in the development of a more than 700,000-square-foot, climate-controlled warehouse facility. With 32.5 million cubic feet of capacity, the facility will provide ANC with a critical piece of infrastructure at the world’s sixth-busiest cargo airport. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210124005094/en/ Alaska Cargo and Cold Storage, LLC signed a 55-year ground lease with the State of Alaska for a 700,000-square-foot cold storage facility strategically located at Ted Stevens Anchorage International Airport, the sixth-busiest cargo airport in the world. (Photo: Ted Stevens Anchorage International Airport) “This project will improve shipping to and through Anchorage, create jobs, and show the world that Alaska is open for business,” said Al
Takeda Named Global Top Employer for Fourth Consecutive Year25.1.2021 03:00:00 EET | Press release
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that it is one of only 16 companies to achieve global Top Employer® certification for 2021. In addition to receiving the global certification for the fourth consecutive year, Takeda was also certified as a Top Employer in four regions and 38 countries. This underscores the company’s commitment to creating an exceptional people experience for its global workforce. For more than 30 years, Top Employers Institute has given annual award certification to companies with outstanding culture, work environments, benefits and opportunities for their people. The Institute certifies organizations based on the results of its HR Best Practices Survey. The survey covers 20 people-centric topic areas, including Career Development, Culture, Diversity & Inclusion, Learning, Sustainability, Values, Well-being and Work Environment. “We are very proud of the global, regional and country recognition we’ve received from Top
GPD Companies, Inc. to Acquire Distrupol22.1.2021 16:33:00 EET | Press release
GPD Companies, Inc., an affiliate of One Rock Capital Partners, LLC (“One Rock”), today announced that it has entered into a definitive agreement to acquire Distrupol, a subsidiary of Univar Solutions Inc. (NYSE: UNVR) and a leading European distributor of thermoplastics to the polymer processing industry. Terms of the transaction, which is expected to close in the first half of 2021, were not disclosed. Headquartered in Surrey, England, with broad geographic reach across Europe, Distrupol has provided value-added sales and application development of thermoplastic resins for over 50 years. Through its decades-long relationships with world class supply partners, the company offers a robust array of superior performance products and solutions that meet the needs of diverse end users from leading and emerging industries, such as the consumer, medical, automotive, and electrical sectors, among others. Distrupol caters to over 1,300 customers across 13 countries with a portfolio of over 4,0
Schlumberger Announces Fourth-Quarter and Full-Year 2020 Results22.1.2021 14:50:00 EET | Press release
Schlumberger Limited (NYSE: SLB) today reported results for the fourth-quarter and full-year 2020. Fourth-Quarter Results (Stated in millions, except per share amounts) Three Months Ended Change Dec. 31, 2020 Sept. 30, 2020 Dec. 31, 2019 Sequential Year-on-year Revenue $5,532 $5,258 $8,228 5% -33% Income (loss) before taxes - GAAP basis $471 $(54) $452 n/m 4% Net income (loss) - GAAP basis $374 $(82) $333 n/m 12% Diluted EPS (loss per share) - GAAP basis $0.27 $(0.06) $0.24 n/m 12% Adjusted EBITDA* $1,112 $1,018 $1,648 9% -33% Adjusted EBITDA margin* 20.1% 19.4% 20.0% 73 bps 6 bps Pretax segment operating income* $654 $575 $1,006 14% -35% Pretax segment operating margin* 11.8% 10.9% 12.2% 90 bps -40 bps Net income, excluding charges & credits* $309 $228 $545 35% -43% Diluted EPS, excluding charges & credits* $0.22 $0.16 $0.39 37% -44% Revenue by Geography International $4,343 $4,210 $5,834 3% -26% North America 1,167 1,034 2,339 13% -50% Other 22 14 55 n/m n/m $5,532 $5,258 $8,228 5% -
JEOL: Release of a New Cold Field Emission Cryo-Electron Microscope CRYO ARM™ 300 II (JEM-3300)22.1.2021 09:00:00 EET | Press release
JEOL Ltd. (TOKYO:6951) (President & COO Izumi Oi) announces the release of a new cold field emission cryo-electron microscope (cryo-EM), the CRYO ARM™ 300 II (JEM-3300), to be released in January 2021. This new cryo-EM has been developed based on the concept of "Quick and easy to operate and get high-contrast and high-resolution images". This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210121005316/en/ Cold Field Emission Cryo-Electron Microscope CRYO ARM(TM) 300 II (JEM-3300) (Photo: Business Wire) Development Background Recent dramatic improvement of resolution in single particle analysis (SPA) using cryo-EM has led to SPA as an essential method for structural analysis of proteins. To address this market, JEOL released the CRYO ARM™ 300 in 2017. Equipped with a cold field emission gun (Cold FEG) for enhanced resolution and a cryo-stage for loading multiple samples, the CRYO ARM™ 300 has continued to achieve best-in-class res
ViiV Healthcare announces FDA approval of Cabenuva (cabotegravir, rilpivirine), the first and only complete long-acting regimen for HIV treatment22.1.2021 01:12:00 EET | Press release
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today announced that the US Food and Drug Administration (FDA) approved Cabenuva, the first and only complete long-acting regimen for the treatment of HIV-1 infection in adults. Cabenuva is provided as a co-pack with two injectable medicines — ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine — dosed once monthly, as an option to replace the current antiretroviral (ARV) regimen in those who are virologically suppressed (HIV-1 RNA less than 50 copies per milliliter [mL]) on a stable regimen, with no history of treatment failure, and with no known or suspected resistance to either cabotegravir or rilpivirine. Prior to initiating treatment of Cabenuva, oral dosing of cabotegravir and rilpivirine should be administered for approximately one month to assess the tolerability of each therapy.1 Lynn Baxter, Head of North America, ViiV H
Incyte Announces Acceptance and Priority Review of BLA for Retifanlimab as a Potential Treatment for Patients with Squamous Cell Carcinoma of the Anal Canal (SCAC)22.1.2021 00:30:00 EET | Press release
Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has accepted for Priority Review its Biologics License Application (BLA) for retifanlimab, an intravenous PD-1 inhibitor, as a potential treatment for adult patients with locally advanced or metastatic squamous cell carcinoma of the anal canal (SCAC) who have progressed on, or who are intolerant of, platinum-based chemotherapy. The BLA submission is based on data from the Phase 2 POD1UM-202 trial evaluating retifanlimab in previously treated patients with locally advanced or metastatic SCAC who have progressed on, or are intolerant of, standard platinum-based chemotherapy. The trial enrolled 94 patients, including several with well-controlled human immunodeficiency virus (HIV) infection. The study, which was recently presented at the European Society for Medical Oncology (ESMO) Virtual Congress 2020, resulted in an objective response rate (ORR) of 14% for retifanlimab monotherapy as determined by inde
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.Visit our pressroom